Edition:
United States

Second Sight Medical Products Inc (EYES.OQ)

EYES.OQ on NASDAQ Stock Exchange Capital Market

2.12USD
4:00pm EDT
Change (% chg)

$-0.11 (-4.93%)
Prev Close
$2.23
Open
$2.23
Day's High
$2.25
Day's Low
$2.09
Volume
34,351
Avg. Vol
89,472
52-wk High
$2.58
52-wk Low
$0.90

Chart for

About

Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Company's product, the Argus II System, treats outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that... (more)

Overall

Beta: 3.26
Market Cap(Mil.): $148.59
Shares Outstanding(Mil.): 66.63
Dividend: --
Yield (%): --

Financials

  EYES.OQ Industry Sector
P/E (TTM): -- 38.82 32.94
EPS (TTM): -0.53 -- --
ROI: -220.25 14.37 12.79
ROE: -220.25 17.21 14.67

BRIEF-Second Sight Reports Q1 Loss Per Share $0.17

* Q1 NON-GAAP LOSS PER SHARE $0.14 EXCLUDING ITEMS Source text for Eikon: Further company coverage:

May 10 2018

BRIEF-Second Sight Completes $10 Mln Private Placement Of Common Stock With Chairman Of Board Of Directors

* SECOND SIGHT COMPLETES $10 MILLION PRIVATE PLACEMENT OF COMMON STOCK WITH GREGG WILLIAMS, CHAIRMAN OF THE BOARD OF DIRECTORS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

May 07 2018

BRIEF-Second Sight Medical Products Says Robert Greenberg's Resignation "Was An Outgrowth Of A Disagreement Over His Reporting Relationship" With Co

* FORMER CHAIMAN ROBERT GREENBERG'S RESIGNATION "WAS AN OUTGROWTH OF A DISAGREEMENT OVER HIS REPORTING RELATIONSHIP" WITH CO

Apr 09 2018

BRIEF-Second Sight Appoints John Blake Chief Financial Officer

* SECOND SIGHT APPOINTS JOHN T. BLAKE CHIEF FINANCIAL OFFICER

Mar 22 2018

BRIEF-Second Sight Appoints Gregg Williams As Chairman Of The Board Of Directors

* SECOND SIGHT APPOINTS GREGG WILLIAMS AS CHAIRMAN OF THE BOARD OF DIRECTORS

Mar 16 2018

BRIEF-Second Sight Q4 Loss Per Share $0.13

* SECOND SIGHT REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 07 2018

BRIEF-Second Sight Announces Market Entry Into Singapore With First Implant Of Argus II Retinal Prosthesis System

* SECOND SIGHT ANNOUNCES MARKET ENTRY INTO SINGAPORE WITH FIRST IMPLANT OF ARGUS II RETINAL PROSTHESIS SYSTEM Source text for Eikon: Further company coverage:

Feb 16 2018

Earnings vs. Estimates